Abstract
Prion diseases are fatal neurodegenerative disorders that affect humans and animals and for which no pharmacological treatment is available. Compounds consisting of two identical moieties joined via an appropriate spacer (i.e. bivalent compounds) have turned out to be effective tools to prevent prion fibril formation and exhibit an improved biological profile with regard to the corresponding monovalent derivatives. In this review we discuss the importance of the bivalent strategy as a viable approach to design new chemical entities to combat prion diseases.
Keywords: Prion protein, protein misfolding diseases, neurodegenerative diseases, protein-protein interaction, bifunctional ligands, molecular tweezers, palindromic compounds.
Current Topics in Medicinal Chemistry
Title:Modulation of Prion by Small Molecules: From Monovalent to Bivalent and Multivalent Ligands
Volume: 13 Issue: 19
Author(s): Matteo Staderini, Giuseppe Legname, Maria Laura Bolognesi and J. Carlos Menéndez
Affiliation:
Keywords: Prion protein, protein misfolding diseases, neurodegenerative diseases, protein-protein interaction, bifunctional ligands, molecular tweezers, palindromic compounds.
Abstract: Prion diseases are fatal neurodegenerative disorders that affect humans and animals and for which no pharmacological treatment is available. Compounds consisting of two identical moieties joined via an appropriate spacer (i.e. bivalent compounds) have turned out to be effective tools to prevent prion fibril formation and exhibit an improved biological profile with regard to the corresponding monovalent derivatives. In this review we discuss the importance of the bivalent strategy as a viable approach to design new chemical entities to combat prion diseases.
Export Options
About this article
Cite this article as:
Staderini Matteo, Legname Giuseppe, Bolognesi Laura Maria and Menéndez Carlos J., Modulation of Prion by Small Molecules: From Monovalent to Bivalent and Multivalent Ligands, Current Topics in Medicinal Chemistry 2013; 13 (19) . https://dx.doi.org/10.2174/15680266113136660176
DOI https://dx.doi.org/10.2174/15680266113136660176 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
EDITORIAL [Hot Topic: QSAR and Computer Aided Drug Design (Guest Editor: Mahmud Tareq Hassan Khan)]
Mini-Reviews in Medicinal Chemistry Protein Folding, Misfolding and Aggregation: Evolving Concepts and Conformational Diseases
Protein & Peptide Letters Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Cytokine-Induced Depression: Current Status and Novel Targets for Depression Therapy
CNS & Neurological Disorders - Drug Targets Histone Deacetylase Inhibitors and Neurodegenerative Disorders: Holding the Promise
Current Pharmaceutical Design Beneficial Effects of Lysosome-Modulating and Other Pharmacological and Nanocarrier Agents on Amyloid-beta-treated Cells
Current Pharmaceutical Biotechnology A2A Receptor Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer’s Disease
Current Pharmaceutical Design Systematic Evaluation of Drug-Loaded Hydrogels for Application in Osteosarcoma Treatment
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Gene Therapy for Parkinsons Disease: Progress and Challenges
Current Gene Therapy Posttranslational Modifications of Tau - Role in Human Tauopathies and Modeling in Transgenic Animals
Current Drug Targets Perspectives on Brain-Targeting Drug Delivery Systems
Current Pharmaceutical Biotechnology Effect of Barley Grain on Memory and Brain’s Oxidative Stress Factors in Male Rats
The Natural Products Journal Synthesis of Functionalized Chromenes from Meldrum’s Acid, 4- Hydroxycoumarin, and Ketones or Aldehydes
Combinatorial Chemistry & High Throughput Screening Lymphocytes in Alzheimer’s Disease Pathology: Altered Signaling Pathways
Current Alzheimer Research Autophagy and Mitochondria: Targets in Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets A Comparative Study Among Various Statistical Tests Using Microarray Gene Expression Data
Current Bioinformatics Neural Stem Cells and Human Induced Pluripotent Stem Cells to Model Rare CNS Diseases
CNS & Neurological Disorders - Drug Targets Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems
Current Gene Therapy